LIFECORE BIOMEDICAL, INC. \DE\ — Director's Dealing 2017

May 10, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2017-05-08

Reporting Person: STEELE GARY T (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-05-08	Common Stock	M	30328	$5.63	Acquired	95030	Indirect
2017-05-08	Common Stock	F	12196	$14	Disposed	82834	Indirect
2017-05-08	Common Stock	M	44672	$5.63	Acquired	127506	Indirect
2017-05-08	Common Stock	F	17964	$14	Disposed	109542	Indirect
2017-05-10	Common Stock	S	26708	$14	Disposed	82834	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-05-08	Incentive Stock Option (Right to Buy)	$14	X	30328	Disposed	2017-05-26	Common Stock (30328)	Indirect
2017-05-08	Nonqualified Stock Options (Right to Buy)	$14	X	44672	Disposed	2017-05-26	Common Stock (44672)	Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.85 to $14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.